127 results
Page 2 of 7
6-K
EX-99.1
9lf74143
30 Jun 22
Statement of Executive Compensation
11:16am
6-K
EX-99.3
o9udaubt cgew31
21 Dec 21
51-102F3 Material Change Report
5:28pm
6-K
EX-99.2
0x6ef1ofrmv
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
j6tos5uuu7 33s
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
jc7g8 41qja
18 Nov 21
Notice of Annual General and Special Meeting of Shareholders
10:36am
6-K
EX-99.1
ygmxc
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
25umboptoqppt 3exlz7
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
xmc4cf
13 Aug 21
RepliCel CEO Provides Corporate Update
12:00am
6-K
EX-99.2
9xzm18bk
13 Aug 21
51-102F3 Material Change Report
12:00am
6-K
EX-99.2
1gff03xbh
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
6-K
EX-99.1
pkfi8llr0
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm
20-F/A
l5fb1t7rnluccbd
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.2
ko5xy3cg3
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
jv35if2agty n7yz0n
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.4
r5q8aamhkvfu jsv91w
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.1
brlckt8l2uv
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm